Vaxcyte recently reported further progress on its next-generation 31-valent pneumococcal conjugate vaccine VAX-31, including first dosing in the adult OPUS-2 Phase 3 trial, completion of enrollment in ...
Organic chemistry is packed with rules about structure and reactivity, especially when it comes to making and breaking ...